MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Gastroenterology_Gastrointestinal (to include Liver, Pancreas & metabolic dysfunction-associated steatotic liver disease (MASLD), Gout, MASH (Metabolic dysfunction-associated steatohepatitis), formerly, NASH (Non-Alcoholic SteatoHepatitis)Non-Alcoholic SteatoHepatitis (NASH)
AEON Biopharma, Inc. (NYSE: AEON)*
Organization & Developments: AEON Biopharma
Parents
AEON Biopharma, Inc. (NYSE: AEON)*
Children
*AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for neurosciences market.
2021: AEON Biopharma Pursues $75 Million IPO
Jumps
Finance & Acquisition: AEON Biopharma
Key People: AEON Biopharma